PPOX

Protoporphyrinogen oxidase · P50336 · PPOX on Sugi Atlas →

13,155 patent compounds predicted against PPOX, 6,600 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3371170 SCHEMBL3371170 0.71 18/20
Acetone Acetone (SCHEMBL532802) 0.61 17/20
SCHEMBL901038 SCHEMBL901038 0.51 17/20
Oxadiazon Oxadiazon (SCHEMBL2484674) 0.80 16/20
Oxadiazon Oxadiazon (SCHEMBL4659772) 0.79 16/20
SCHEMBL39055 SCHEMBL39055 0.65 16/20
Oxadiazon Oxadiazon (SCHEMBL38813) 1.00 14/20
Oxadiazon Oxadiazon (SCHEMBL1068568) 1.00 14/20
Dimefuron Dimefuron (SCHEMBL68325) 0.47 14/20
SCHEMBL4077918 SCHEMBL4077918 0.40 13/20
Pentoxazone Pentoxazone (SCHEMBL38904) 0.51 12/20
SCHEMBL5712847 SCHEMBL5712847 0.39 12/20
SCHEMBL3668708 SCHEMBL3668708 0.78 11/20
SCHEMBL1535840 SCHEMBL1535840 0.65 11/20
SCHEMBL203565 SCHEMBL203565 0.39 10/20
SCHEMBL3246917 SCHEMBL3246917 0.75 9/20
SCHEMBL38427 SCHEMBL38427 0.51 8/20
SCHEMBL314005 SCHEMBL314005 0.51 8/20
Flumiciorac-Pentyl Flumiciorac-Pentyl (SCHEMBL38955) 0.57 7/20
Flumipropyn Flumipropyn (SCHEMBL38980) 0.54 6/20

Clinical trials — most relevant to PPOX by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel PHASE4UNKNOWN
COMS for Chronic Ulcers Treatment PHASE4RECRUITING
Porphozym in the Treatment of Acute Attacks in AIP PHASE2/PHASE3COMPLETED
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma PHASE3COMPLETED
Role of Vitamin E in Gaucher Disease Patients PHASE3COMPLETED
Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria PHASE2COMPLETED
Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria PHASE1/PHASE2COMPLETED
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE PHASE2UNKNOWN
Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction? PHASE1/PHASE2COMPLETED
Daylight Photodynamic Therapy for Actinic Keratosis PHASE1COMPLETED
Hemin in Healthy Subjects PHASE1COMPLETED
Nitrite Infusion Studies PHASE1COMPLETED
Transbroncheal Novel PDT Peripheral Lung Tumor Ablation With 5-ALA nanNOT_YET_RECRUITING
Effects of Fos Biomedical Device on Diabetes Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes nanCOMPLETED
Studies in Porphyria I: Characterization of Enzyme Defects nanUNKNOWN
An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2 nanCOMPLETED
An Evaluation of Low Level Laser Light Therapy for Autistic Disorder nanCOMPLETED
Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria nanCOMPLETED
A Feasibility Study: Assessing Photobiomodulation in Myalgic Encephalomyelitis nanUNKNOWN
Leg Ulcers Standards of Care Enhancement nanCOMPLETED
Transcranial Photobiomodulation for the Treatment of Pediatric Depression nanWITHDRAWN
Mitochondrial Oxygen Measurement Variability in Critically Ill Patients (INOX Variability Study) nanCOMPLETED
Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN nanCOMPLETED
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC)) nanCOMPLETED
Covid-19: Possible Role of Neutrophil Extracellular Traps nanUNKNOWN
Portable Measurement of Protoporphyrin IX in the Skin nanCOMPLETED
Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With ADHD nanCOMPLETED
Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines nanUNKNOWN
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy nanRECRUITING
Effectiveness of Low-level Laser Therapy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PPOX binder may also engage these)

ProteinNameSimilarity
Q60HD5 1.000 Q60HD5 →
P56602 1.000 P56602 →
P51175 0.999 P51175 →
HDAC10 Polyamine deacetylase HDAC10 0.954 landscape →
Q501J2 0.951 Q501J2 →
E1BNQ4 0.951 E1BNQ4 →
Q53HV7 0.950 Q53HV7 →
Q923K4 0.950 Q923K4 →
Q3T0A0 0.950 Q3T0A0 →
Q8BZG5 0.949 Q8BZG5 →
Q8BNV1 0.949 Q8BNV1 →
P60487 0.949 P60487 →
Q9JLV6 0.949 Q9JLV6 →
Q59I47 0.949 Q59I47 →
Q8IVS8 0.948 Q8IVS8 →
Q0VGK3 0.948 Q0VGK3 →
Q8QZY2 0.948 Q8QZY2 →
O55240 0.947 O55240 →
Q2KJF7 0.947 Q2KJF7 →
Q32M88 0.947 Q32M88 →
Q9TUI8 0.947 Q9TUI8 →
Q6XQN1 0.947 Q6XQN1 →
Q8CC86 0.947 Q8CC86 →
Q8VD52 0.946 Q8VD52 →
F1NZI4 0.946 F1NZI4 →
Q8BP56 0.946 Q8BP56 →
Q6AYG0 0.946 Q6AYG0 →
Q865R1 0.945 Q865R1 →
A2AI05 0.945 A2AI05 →
PNKP Bifunctional polynucleotide phosphatase/kinase 0.945 landscape →